Panbela Therapeutics Inc (PBLA)
0.4102
+0.03
(+7.58%)
USD |
OTCM |
May 03, 16:00
Panbela Therapeutics Free Cash Flow: -25.25M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -25.25M |
September 30, 2023 | -27.17M |
June 30, 2023 | -22.09M |
March 31, 2023 | -20.54M |
December 31, 2022 | -15.94M |
September 30, 2022 | -13.16M |
June 30, 2022 | -12.93M |
March 31, 2022 | -9.763M |
December 31, 2021 | -7.245M |
September 30, 2021 | -6.13M |
June 30, 2021 | -5.536M |
March 31, 2021 | -4.699M |
December 31, 2020 | -3.854M |
September 30, 2020 | -3.613M |
June 30, 2020 | -3.301M |
March 31, 2020 | -3.076M |
December 31, 2019 | -2.739M |
September 30, 2019 | -2.029M |
June 30, 2019 | -2.216M |
March 31, 2019 | -2.582M |
December 31, 2018 | -2.387M |
September 30, 2018 | -3.008M |
June 30, 2018 | -2.629M |
Date | Value |
---|---|
March 31, 2018 | -2.918M |
December 31, 2017 | -3.402M |
September 30, 2017 | -3.447M |
June 30, 2017 | -4.125M |
March 31, 2017 | -2.928M |
December 31, 2016 | -2.398M |
September 30, 2016 | -2.448M |
June 30, 2016 | -2.387M |
March 31, 2016 | -3.532M |
December 31, 2015 | -3.897M |
September 30, 2015 | -4.188M |
June 30, 2015 | -5.517M |
March 31, 2015 | -4.266M |
December 31, 2014 | -3.343M |
September 30, 2014 | -2.073M |
June 30, 2014 | 0.1305M |
March 31, 2014 | 0.0634M |
December 31, 2013 | -0.0405M |
September 30, 2013 | -0.1724M |
June 30, 2013 | -0.181M |
March 31, 2013 | -0.0226M |
December 31, 2012 | 0.0371M |
Free Cash Flow Range, Past 5 Years
-27.17M
Minimum
Sep 2023
-2.029M
Maximum
Sep 2019
-10.07M
Average
-6.13M
Median
Sep 2021
Free Cash Flow Benchmarks
NovaBay Pharmaceuticals Inc | -4.15M |
Palatin Technologies Inc | -26.75M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.20M |
Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.08M |
Cash from Financing (Quarterly) | 4.749M |
Free Cash Flow Per Share (Quarterly) | -6.416 |
Free Cash Flow Yield | -36.45K% |